Skip to search formSkip to main contentSkip to account menu

Myeloablative Agonists

Known as: Agonist, Myeloablative, Agonists, Myeloablative, Myeloablative Agonist 
Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION.
National Institutes of Health

Related topics

Related topics

10 relations

Narrower (4)

BusulfanCyclophosphamideMelphalanThiotepa
In Bloodagonistsantagonists & inhibitorsaspects of radiation effects

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents.
Review
2015
Review
2015
Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival.
2014
2014
Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk…
2011
2011
A comparison of immune reconstitution and graft‐versus‐host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric…
Immune reconstitution appears to be delayed following myeloablative conditioning (MAC) and umbilical cord blood transplantation… 
2011
2011
Comparison of reduced intensity and myeloablative conditioning regimens for stem cell transplantation in patients with malignancies: a meta‐analysis
Shi‐Xia X, Hai‐Qin X, Xian‐Hua T, Bo F, Xiang‐Feng T. Comparison of reduced intensity and myeloablative conditioning regimens for… 
Review
2010
Review
2010
Hematopoietic stem cell transplantation for multiple myeloma beyond 2010.
Autologous stem cell transplantation (ASCT) is considered the gold standard in the frontline therapy of younger patients with… 
2007
2007
Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation
Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation 
2007
2007
Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides
Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for… 
Review
2006
Review
2006
Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options
Myeloablative sibling-matched allogeneic transplantation for adult acute lymphoblastic leukaemia provides the best outcome, but… 
1990
1990
Bone marrow transplantation from histocompatible sibling donors for patients with acute lymphoblastic leukemia.
Between March 1977 and September 1988, 150 patients with acute lymphoblastic leukemia (ALL) were treated with myeloablative… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)